Christopher P Tinworth

11PUBLICATIONS
49CO-AUTHORS
Innate immunityBiomolecular modelling and designMolecular targetsComputational chemistryProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo.

|Apr 13, 2026
Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 Inhibitors.

Robert P Law, Ian D Wall, Richard Lonsdale

|Dec 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.

Ross P Hryczanek, Andrew S Hackett, Paul Rowland

|Jan 31, 2023
A two-faced selectivity solution to target SMARCA2 for cancer therapy.

John D Harling, Christopher P Tinworth

|Sep 06, 2022
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs).

Qisi Zhang, Cyrille S Kounde, Milon Mondal

|Sep 23, 2020
Computational Mapping of Dirhodium(II) Catalysts.

Adam I Green, Christopher P Tinworth, Stuart Warriner

Pageof 2

Frequent Collaborators

4 joint publications

Robert J Young

4 joint publications

Efstratios Stratikos

3 joint publications

John D Harling

3 joint publications

Richard Lonsdale